Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Gypsyamber DʼSouza(Johns Hopkins University), Carole Fakhry(Johns Hopkins University), Simon R. Best(Johns Hopkins University), Tanya Troy(Johns Hopkins University), Noemi Bender(German Cancer Research Center), Phillip M. Pierorazio(University of Pennsylvania Health System), Gwendolyn Clemens(Johns Hopkins University), Linda Struijk(DDL Diagnostic Laboratory), Robert I. Haddad(Georgetown University), Tim Waterboer(German Cancer Research Center), Howard D. Strickler(Albert Einstein College of Medicine), Dorothy J. Wiley(University of California, Los Angeles), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Rachel Castillo(Johns Hopkins University)
Cited by 46
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926